Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030788772> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2030788772 endingPage "47" @default.
- W2030788772 startingPage "47" @default.
- W2030788772 abstract "Background: A double-blind, randomized, placebo-controlled Homoeopathic Pathogenetic Trial (HPT/Drug Proving) of Hydroquinone was conducted, using the accepted guidelines, ethical approval and scientific documentation The potentization method was standardized. Toward enhancing the quality of HPT, the investigator proposed and evaluated the data using the Quantitative Pathogenetic Index and Qualitative Pathogenetic Index. Usable symptoms were derived from the study. The medicine was suggested for the treatment of vitiligo, based on its known toxicological effects. HPT of a new medicinal substance, using the established parameters, to evaluate symptoms in healthy volunteers was carried out using a controlled experiment. Aims: The aim of the study was to conduct a HPT using the accepted and scientific guidelines to derive clinically usable symptoms. Material and Methods: A double-blind, randomized, placebo-controlled homoeopathic pathogenetic trial was conducted in 22 volunteers (provers), out of whom 15 received Hydroquinone in 30C potency, thrice daily, for four weeks, while seven received the placebo. The volunteer's symptoms during the initial seven days of the run-in period were carefully noted, and these were used as a filter, by elimination of the same symptoms in that volunteer during the verum phase. Thorough documentation such as Informed Consent Form, approval by the Ethics Committee, laboratory investigations, and safety and ethical measures, were taken care of. The volunteers were trained to write data in the prescribed diaries which was analyzed at the end. The investigator introduced Quantitative and Qualitative Pathogenetic Indices as parameters in the evaluation of the data derived from the HPT. Results: The HPT of Hydroquinone exhibited qualitatively distinct symptoms, which could be applied in clinical practice. Safe use was documented. An anecdotal study supported the proposed efficacy of Hydroquinone for the treatment of vitiligo and further exploration could be carried out. Conclusion: The HPT of Hydroquinone brought in qualitative symptoms. It was noted that a potentized preparation could produce many functional symptoms, but could not produce degenerative pathological symptoms such as vitiligo. The preparation could be used by the profession for vitiligo on the basis of its toxicological effects, supported by the anecdotal study. The Quantitative and Qualitative Pathogenetic Indices could further be used in future HPTs as a tool." @default.
- W2030788772 created "2016-06-24" @default.
- W2030788772 creator A5065920736 @default.
- W2030788772 date "2013-01-01" @default.
- W2030788772 modified "2023-10-14" @default.
- W2030788772 title "Hydroquinone : Homoeopathic pathogenetic trial" @default.
- W2030788772 doi "https://doi.org/10.4103/0974-7168.116621" @default.
- W2030788772 hasPublicationYear "2013" @default.
- W2030788772 type Work @default.
- W2030788772 sameAs 2030788772 @default.
- W2030788772 citedByCount "3" @default.
- W2030788772 countsByYear W20307887722015 @default.
- W2030788772 countsByYear W20307887722019 @default.
- W2030788772 countsByYear W20307887722022 @default.
- W2030788772 crossrefType "journal-article" @default.
- W2030788772 hasAuthorship W2030788772A5065920736 @default.
- W2030788772 hasBestOaLocation W20307887721 @default.
- W2030788772 hasConcept C118552586 @default.
- W2030788772 hasConcept C126322002 @default.
- W2030788772 hasConcept C141071460 @default.
- W2030788772 hasConcept C142724271 @default.
- W2030788772 hasConcept C144024400 @default.
- W2030788772 hasConcept C153997805 @default.
- W2030788772 hasConcept C168563851 @default.
- W2030788772 hasConcept C176762198 @default.
- W2030788772 hasConcept C17744445 @default.
- W2030788772 hasConcept C1862650 @default.
- W2030788772 hasConcept C199360897 @default.
- W2030788772 hasConcept C204787440 @default.
- W2030788772 hasConcept C27081682 @default.
- W2030788772 hasConcept C2776970089 @default.
- W2030788772 hasConcept C2779318504 @default.
- W2030788772 hasConcept C3116431 @default.
- W2030788772 hasConcept C36289849 @default.
- W2030788772 hasConcept C41008148 @default.
- W2030788772 hasConcept C512399662 @default.
- W2030788772 hasConcept C535046627 @default.
- W2030788772 hasConcept C56666940 @default.
- W2030788772 hasConcept C68122502 @default.
- W2030788772 hasConcept C71924100 @default.
- W2030788772 hasConceptScore W2030788772C118552586 @default.
- W2030788772 hasConceptScore W2030788772C126322002 @default.
- W2030788772 hasConceptScore W2030788772C141071460 @default.
- W2030788772 hasConceptScore W2030788772C142724271 @default.
- W2030788772 hasConceptScore W2030788772C144024400 @default.
- W2030788772 hasConceptScore W2030788772C153997805 @default.
- W2030788772 hasConceptScore W2030788772C168563851 @default.
- W2030788772 hasConceptScore W2030788772C176762198 @default.
- W2030788772 hasConceptScore W2030788772C17744445 @default.
- W2030788772 hasConceptScore W2030788772C1862650 @default.
- W2030788772 hasConceptScore W2030788772C199360897 @default.
- W2030788772 hasConceptScore W2030788772C204787440 @default.
- W2030788772 hasConceptScore W2030788772C27081682 @default.
- W2030788772 hasConceptScore W2030788772C2776970089 @default.
- W2030788772 hasConceptScore W2030788772C2779318504 @default.
- W2030788772 hasConceptScore W2030788772C3116431 @default.
- W2030788772 hasConceptScore W2030788772C36289849 @default.
- W2030788772 hasConceptScore W2030788772C41008148 @default.
- W2030788772 hasConceptScore W2030788772C512399662 @default.
- W2030788772 hasConceptScore W2030788772C535046627 @default.
- W2030788772 hasConceptScore W2030788772C56666940 @default.
- W2030788772 hasConceptScore W2030788772C68122502 @default.
- W2030788772 hasConceptScore W2030788772C71924100 @default.
- W2030788772 hasIssue "2" @default.
- W2030788772 hasLocation W20307887721 @default.
- W2030788772 hasOpenAccess W2030788772 @default.
- W2030788772 hasPrimaryLocation W20307887721 @default.
- W2030788772 hasRelatedWork W2030788772 @default.
- W2030788772 hasRelatedWork W2030926149 @default.
- W2030788772 hasRelatedWork W2091546201 @default.
- W2030788772 hasRelatedWork W2108624693 @default.
- W2030788772 hasRelatedWork W2145814552 @default.
- W2030788772 hasRelatedWork W2267623227 @default.
- W2030788772 hasRelatedWork W2323925132 @default.
- W2030788772 hasRelatedWork W2468919325 @default.
- W2030788772 hasRelatedWork W2581039363 @default.
- W2030788772 hasRelatedWork W2899356148 @default.
- W2030788772 hasVolume "7" @default.
- W2030788772 isParatext "false" @default.
- W2030788772 isRetracted "false" @default.
- W2030788772 magId "2030788772" @default.
- W2030788772 workType "article" @default.